Neurologie
| traitement | |
|---|---|
| Thérapie par cellules souches pour la neuropathie | $20021.02 - $26694.7 |
| Traitement de la sclérose en plaques par cellules souches | $20021.02 - $26694.7 |
Vitalia Merkez Prime Hospital is a private multi-specialty medical center in Gebze, Turkey. The team dedicates itself to neurology and pediatrics. Vitalia Merkez Prime Hospital serves both adults and children. Every year, 2,000 patients choose Vitalia Merkez Prime Hospital for medical care. Patients from Europe, the Commonwealth, Arab League States, and the CIS countries visit the clinic most often.
| traitement | |
|---|---|
| Thérapie par cellules souches pour la neuropathie | $20021.02 - $26694.7 |
| Traitement de la sclérose en plaques par cellules souches | $20021.02 - $26694.7 |
| traitement | |
|---|---|
| Thérapie par cellules souches | $20021.02 - $26694.7 |
Vitalia Merkez Prime Hospital specializes in regenerative medicine, particularly stem cell and exosome therapies. Stem cells can regenerate damaged tissues and organs, while exosomes — tiny vesicles released by cells — enhance cell communication and repair. Stem cells offer the potential to heal conditions such as heart disease, neurodegenerative disorders, and spinal cord injuries. Exosomes are particularly effective for inflammatory conditions, autoimmune diseases, and cancer.
The hospital's core team includes experts with a decade of experience in regenerative medicine and neurodevelopmental disorders. Dr. Alex, the Senior Medical Advisor, holds a Bachelor of Science (B.Sc), a Master of Science (M.Sc), and a Doctor of Medicine (M.D.) degree. He brings 15 years of experience in stem cell research and application. The hospital's nurses receive special training in administering stem cell and exosome therapies. They provide personalized care from consultation to follow-up.
Vitalia Merkez Prime Hospital is also committed to education and community engagement. It regularly hosts seminars and workshops to inform patients and healthcare professionals about the latest advancements in regenerative therapies.